Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

HOLDING PHARMACIE BONNET : revenue, balance sheet and financial ratios

HOLDING PHARMACIE BONNET is a French company founded 3 years ago, specialized in the sector Gestion de fonds. Based in SALINDRES (30340), this company of category PME shows in 2025 a net income positive of 101 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - HOLDING PHARMACIE BONNET (SIREN 921781522)
Indicator 2025 2024 2023
Revenue N/C N/C N/C
Net income 100 922 € 33 048 € 121 009 €
EBITDA -1 039 € -1 108 € -2 161 €
Net margin N/C N/C N/C

Revenue and income statement

In 2025, HOLDING PHARMACIE BONNET generates positive net income of 101 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2025: 121 k€ -> 101 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-1 039 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-1 039 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

100 922 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

99.691%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
HOLDING PHARMACIE BONNET

Sector positioning

Debt ratio
0.0 2025
2023
2024
2025
Q1: 0.0
Med: 11.05
Q3: 95.39
Excellent

In 2025, the debt ratio of HOLDING PHARMACIE BONNET (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
99.69% 2025
2023
2024
2025
Q1: 9.39%
Med: 52.08%
Q3: 89.29%
Excellent

In 2025, the financial autonomy of HOLDING PHARMACIE BONNET (99.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.12 years
Q3: 3.48 years
Excellent -24 pts over 3 years

In 2025, the repayment capacity of HOLDING PHARMACIE BONNET (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 6952.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

6952.028

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
HOLDING PHARMACIE BONNET

Sector positioning

Liquidity ratio
6952.03 2025
2023
2024
2025
Q1: 117.65
Med: 590.18
Q3: 4189.62
Excellent

In 2025, the liquidity ratio of HOLDING PHARMACIE BONNET (6952.03) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2025
2023
2024
2025
Q1: -77.28x
Med: 0.0x
Q3: 0.0x
Good

In 2025, the interest coverage of HOLDING PHARMACIE BONNET (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Positioning of HOLDING PHARMACIE BONNET in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions). This range of 131 032€ to 755 139€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
131k€ 258k€ 755k€
258 458 € Range: 131 032€ - 755 139€
NAF 5 année 2025

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare HOLDING PHARMACIE BONNET with other companies in the same sector:

Frequently asked questions about HOLDING PHARMACIE BONNET

What is the revenue of HOLDING PHARMACIE BONNET ?

The revenue of HOLDING PHARMACIE BONNET is not publicly disclosed (confidential accounts filed with INPI).

Is HOLDING PHARMACIE BONNET profitable?

Yes, HOLDING PHARMACIE BONNET generated a net profit of 101 k€ in 2025.

Where is the headquarters of HOLDING PHARMACIE BONNET ?

The headquarters of HOLDING PHARMACIE BONNET is located in SALINDRES (30340), in the department Gard.

Where to find the tax return of HOLDING PHARMACIE BONNET ?

The tax return of HOLDING PHARMACIE BONNET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does HOLDING PHARMACIE BONNET operate?

HOLDING PHARMACIE BONNET operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.